Short answer
MERIT MEDICAL SYSTEMS INC (MMSI) filed its Q3 2025 10-Q quarterly report on Oct 30, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $384M (up 13.0% year over year) with net income of $28M.
Q3 2025 key financials · XBRL
- Revenue
- $384M
- +13.0% YoY · +0.4% QoQ
- Net income
- $28M
- −2.4% YoY · −14.8% QoQ
- Operating margin
- 11.1%
- Gross margin
- 48.5%
- EPS (diluted)
- $0.46
- −4.2% YoY · −14.8% QoQ
Source: XBRL data from the MERIT MEDICAL SYSTEMS INC (MMSI) Q3 2025 10-Q on SEC EDGAR. USD.
MERIT MEDICAL SYSTEMS INC Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Profitability or margin figures not provided
- Management highlights multiple risks and uncertainties impacting future results without updated guidance or forecast
Risk Factors
- New leadership transition risk triggered by CEO Fred Lampropoulos resignation and Martha Aronson appointment effective October 3, 2025
- Most material update: increased labor cost risk in Mexico due to inflationary pressures and labor shortages impacting talent retention
- No new material regulatory, legal, or compliance risks disclosed this quarter
- Operational risk: potential disruption and inefficiencies from CEO transition affecting customer, supplier, and investor relationships
- Financial risk: no key man life insurance on CEO or Executive Chairman increases vulnerability to sudden leadership loss
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MERIT MEDICAL SYSTEMS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.